Product containing precisely tapentadol 50 milligram/1 each modified-release oral tablet 1 tablet tablet (clinical drug)
| Code | 18672211000001103 |
|---|---|
| Semantic tag | clinical drug |
| Module | uk-clinical |
| Definition | defined |
| Effective time | 20250924 |
777675005Tapentadol
medicinal product
10363801000001108Virtual medicinal product
product
39584511000001108Ationdo SR 50mg tablets (Grunenthal Ltd)
real clinical drug
42998411000001103Lupaxis 50mg prolonged-release tablets (Dr Reddy's Laboratories (UK) Ltd)
real clinical drug
18663511000001100Palexia SR 50mg tablets (Grunenthal Ltd)
real clinical drug
42674611000001102Tadomon 50mg prolonged-release tablets (G.L. Pharma UK Ltd)
real clinical drug
42899711000001108Tapentadol 50mg modified-release tablets (A A H Pharmaceuticals Ltd)
real clinical drug
42617711000001105Tapentadol 50mg modified-release tablets (Alliance Healthcare (Distribution) Ltd)
real clinical drug
42995811000001105Tapentadol 50mg modified-release tablets (Aspire Pharma Ltd)
real clinical drug
42540411000001100Tapentadol 50mg modified-release tablets (Krka UK Ltd)
real clinical drug
43142211000001101Tapentadol 50mg modified-release tablets (Medical Valley Invest AB)
real clinical drug
43158111000001107Tapentadol 50mg modified-release tablets (Medihealth (Northern) Ltd)
real clinical drug
42769611000001104Tapentadol 50mg modified-release tablets (Viatris UK Healthcare Ltd)
real clinical drug
43213511000001101Vecicom 50mg prolonged-release tablets (Celix Pharma Ltd)
real clinical drug